2020 annual financial data
REGENXBIO 2020 Net margin
Direct answer
Net margin was -71.98%.
Operating income was -119,233,000 USD and net income was -111,250,000 USD.
Operating cash flow was -54,061,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 154,567,000 USD
- Operating income
- -119,233,000 USD
- Net income
- -111,250,000 USD
- Operating cash flow
- -54,061,000 USD